Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort.
Adrian CiureaSeraphina KisslingKristina BürkiXenofon BaraliakosManouk de HoogeMonika HebeisenEleftherios PapagiannoulisPascale ExerRené BrämMichael J NissenBurkhard MöllerDiego KyburzMichael AndorOliver DistlerAlmut SchererRaphael MicheroliPublished in: RMD open (2022)
Patients with r22axSpA are comparable to nr-axSpA patients but differ from patients with more severe sacroiliac damage with regard to treatment effectiveness and spinal radiographic progression. Therefore, current differentiation between nr-axSpA and radiographic disease seems of limited use for outcome prediction.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- randomized controlled trial
- chronic kidney disease
- systematic review
- oxidative stress
- spinal cord
- electronic health record
- early onset
- rheumatoid arthritis
- disease activity
- cross sectional
- machine learning
- spinal cord injury
- patient reported outcomes
- systemic lupus erythematosus
- combination therapy
- artificial intelligence
- drug induced